COMMUNIQUÉS West-GlobeNewswire

Dr. Michael K. Pugsley Joins Veritas Pharma’s Advisory Board
18/04/2018
VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce that Dr. Michael K. Pugsley PhD, FBPhS, [...]
Basilea reports start of clinical phase 3 study in Japan by Asahi Kasei Pharma with antifungal isavuconazole
18/04/2018
Basel, Switzerland, April 18, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its license partner Asahi Kasei Pharma Corporation ("Asahi Kasei Pharma") has started enrollment in a clinical phase 3 [...]
Curetis: Novel Products and Study Data to be Presented at ECCMID 2018
18/04/2018
Curetis: Novel Products and Study Data to be Presented at ECCMID 2018 Introduction of Unyvero UTI Application Cartridge Update on A30 RQ Analyzer to be provided MGI/Curetis NGS Solution for Molecular Microbiology to be [...]
GUERBET : 1st quarter 2018 revenue
18/04/2018
€196.5 million at constant exchange rates: -3.2% Villepinte, April 18, 2018 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is reporting revenue of €183.2 million [...]
GUERBET : Chiffre d'affaires 1er trimestre 2018
18/04/2018
196,5 M€ à taux de change constant : -3,2% Villepinte, le 18 avril 2018 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, publie un chiffre d'affaires de [...]
GUERBET : GEAR 2023 strategic plan
18/04/2018
Villepinte, April 18, 2018 - Guerbet ( the "Company "), a global specialist in contrast agents and solutions for medical imaging, has released today its GEAR 2023 strategic plan. About Guerbet Guerbet is a leading [...]
GUERBET : Plan stratégique GEAR 2023
18/04/2018
Villepinte, 18 avril 2018 - Guerbet (la « Société ») , spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, publie aujourd'hui son plan stratégique GEAR 2023. A propos de Guerbet Guerbet [...]
DiaMedica Issues Stock Option Grants
18/04/2018
MINNEAPOLIS, April 17, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the " Company ") (TSX-V: DMA ) (OTCQB:DMCAF), today announced the issuance of 2,551,000 stock options to various officers and directors of the [...]
ALK’s partner for Japan, Torii, secures pricing for new Japanese cedar SLIT-tablet
18/04/2018
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that its partner for Japan, Torii Pharmaceutical Co., Ltd., has agreed a price with authorities and secured a listing on Japan’s National Health Insurance [...]
Bellicum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
18/04/2018
HOUSTON, April 17, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and [...]
Maple Leaf Begins Constructing the Building Structure on its Telkwa, British Columbia Facility
18/04/2018
CALGARY, Alberta, April 17, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSXV:MGW) (OTCQB:MGWFF) is pleased to announce that it has received a progress report from the [...]
National Research Corporation Announces Consummation of Class B Common Stock Recapitalization
17/04/2018
LINCOLN, Neb., April 17, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRCIA ) (NASDAQ: NRCIB ) today announced that its shareholders approved the December 2017 announced recapitalization plan pursuant [...]
Encinitas Dentist Urges Screenings in Light of Oral Cancer Awareness Month
17/04/2018
With April marking the arrival of National Oral Cancer Awareness Month, Dr. Cathy Santone of Encinitas Cosmetic Dentistry is encouraging patients to incorporate a screening into their routine dental visit and donating [...]
Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05%
17/04/2018
BUENA, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Marrone Bio Innovations, Inc. Announces Proposed Public Offering of Common Stock
17/04/2018
DAVIS, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) or ("the Company"), a leading provider of bio-based pest management and plant health products for the agriculture, turf and [...]
Retrophin to Report First Quarter 2018 Financial Results
17/04/2018
SAN DIEGO, April 17, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced it will report first quarter 2018 financial results on Tuesday, May 1, 2018 after the close of the U.S. financial markets. [...]
EyeGate Announces Completion of $11.25 Million Public Offering
17/04/2018
WALTHAM, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (Nasdaq: EYEG ) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products [...]
Globus Medical Schedules First Quarter 2018 Earnings Release and Conference Call
17/04/2018
AUDUBON, Penn., April 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2018 after [...]
Medigus and HC Marbella International Hospital Announce First MUSE™ Procedure for GERD Treatment in Spain
17/04/2018
-Leading gastroenterologist reports successful procedure with comprehensive endoscopic device- OMER, Israel, and MARBELLA, Spain, April 17, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS ) (TASE: MDGS ), a medical [...]

Pages